Medication info

BM Heparin Sodium Injection 20000 Units

Prescription medication정맥 · 피하
Ingredient · strength
Heparin Sodium›Strength being verified
Manufacturer / importer
(주)한국비엠아이
Appearance
A clear liquid that is colorless or pale yellow contained in a brown vial
Packaging
20mL/vial X 10 vials
Approval status
Active

MFDS item code 201308449 · Notified 2013.07.29 · Insurance code 654802151

Summary

Main use
Prevention and treatment of thrombosis and embolism, anticoagulant effect
Who receives it
Adults
Adult administration
Typically administered intravenously or added to circulating blood during extracorporeal circulation. 1. Extracorporeal Circulation 1) Artificial Kidney (1) Systemic Heparinization: Administer heparin sodium 1,000 to 5,000 IU before starting dialysis, and after dialysis starts, continuously administer 500 to 1,500 IU per hour or intermittently add 500 to 1,500 IU every hour. (2) Local Heparinization:

Ingredients

Manufacturer
(주)한국비엠아이

Efficacy & effects

Prevention and treatment of thrombosis and embolism, anticoagulant effect

  • Thrombosis
  • pulmonary embolism
  • embolic atrial fibrillation
  • coagulopathy
  • blood coagulation
  • cerebral thrombosis
  • coronary obstruction
  • peripheral vascular embolism
View approved original text

This medication is used in various situations related to thrombosis. It is effective in preventing and treating thrombosis and pulmonary embolism after surgery, as well as in preventing and treating embolic atrial fibrillation. Additionally, it is used in the diagnosis and treatment of acute and chronic coagulopathy, for preventing blood coagulation during vascular and cardiac surgery, and is helpful in preventing cerebral thrombosis caused by cerebral hemorrhage. It is also used to prevent blood coagulation during transfusions, extracorporeal circulation, dialysis, or in the laboratory, as well as in the treatment of coronary occlusion associated with acute myocardial infarction and peripheral vascular embolism. This medication is used for a variety of thrombotic conditions to improve the symptoms of patients.

How it is given

Adult administration

Typically administered intravenously or added to circulating blood during extracorporeal circulation. 1. Extracorporeal Circulation 1) Artificial Kidney (1) Systemic Heparinization: Administer heparin sodium 1,000 to 5,000 IU before starting dialysis, and after dialysis starts, continuously administer 500 to 1,500 IU per hour or intermittently add 500 to 1,500 IU every hour. (2) Local Heparinization:

Precautions

This medication is very powerful, so it must be used only under the strict supervision of a physician. Patients with diseases that have a high risk of bleeding should use this medication with caution, as bleeding can occur in almost any part of the body for patients who have received this drug. The benzyl alcohol component contained in this medication can cause life-threatening respiratory problems in premature infants or newborns, so it should not be used in these patients. It should not be administered to patients who have had an allergic reaction to this medication or its components, whose blood coagulation tests have been outside normal ranges, or those with bleeding or a tendency to bleed. Patients with severe liver or kidney disease, those who have recently had surgery on the central nervous system or eyes, and patients who have received spinal or epidural anesthesia should also be evaluated carefully before using this medication. Patients with consumptive coagulopathy, pregnant women in their late stages, children or older adults, and individuals with alcohol dependence should have their blood coagulation status periodically checked and observed closely when using this drug. This medication can cause various side effects such as bleeding, thrombocytopenia, liver function abnormalities, allergic reactions, skin issues, and local pain, so any unusual symptoms should be reported to medical personnel immediately. Blood coagulation tests should be conducted to adjust the dosage of this medication, and if bleeding worsens or there is a significant drop in platelet numbers, administration should be stopped. Thrombocytopenia caused by this medication can be associated with serious thrombosis, so regular platelet count tests and careful monitoring are necessary. This drug can interact with various other medications, so if you are taking other medications, be sure to inform your doctor or pharmacist. Women who are pregnant or breastfeeding should use this medication with increased caution due to the risk of bleeding in the fetus and newborn, and because the benzyl alcohol component can pass through the placenta and into breast milk. Safety in children has not been adequately established, so special caution is required when administering it to children. Older adults have a higher risk of bleeding, so they should be observed more carefully when using this medication. In case of overdose, severe bleeding may occur, so notify medical personnel immediately, and if necessary, administer the antidote protamine sulfate to neutralize this medication. Intramuscular injections should be avoided due to the risk of bruising, and it should not be mixed with antihistamines for injection.

Side effects and when to seek care immediately

Serious side effects

Hives, severe swelling (angioedema), chest tightness (pressure sensation), difficulty breathing, hypotension, shock (severe allergic reaction), severe rash with high fever, skin peeling (hemorrhagic necrosis), dyspnea, bronchial asthma, asthma attacks, cyanosis, severe skin reactions, thrombocytopenia, heparin-induced thrombocytopenia (HIT), thrombosis, liver abnormalities (elevations in γ-GTP, LDH, AST, ALT), liver

Mild side effects

  • Itching
  • chills
  • fever
  • rhinitis
  • tearing
  • conjunctivitis
  • tachycardia
  • pressure sensation
  • nausea
  • vomiting
Show 15 more
  • hypotension
  • bronchospasm
  • hair loss
  • vitiligo
  • bleeding necrosis
  • local pain-related hematoma
  • priapism
  • diabetes
  • hyperkalemia
  • hyperaldosteronism
  • metabolic acidosis
  • elevated lipase levels
  • erythema
  • mild pain
  • ulcers

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a tightly sealed container that does not allow light to enter. Additionally, it is important to maintain the storage temperature between 1 degree and 30 degrees Celsius room temperature. Proper storage will help maintain the effectiveness of the medication and prevent deterioration.

Appearance and packaging

Appearance

A clear liquid that is colorless or pale yellow contained in a brown vial

Package unit

20mL/vial X 10 vials

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.